AU2867784A - Aircraft undercarriage assemblies - Google Patents
Aircraft undercarriage assembliesInfo
- Publication number
- AU2867784A AU2867784A AU28677/84A AU2867784A AU2867784A AU 2867784 A AU2867784 A AU 2867784A AU 28677/84 A AU28677/84 A AU 28677/84A AU 2867784 A AU2867784 A AU 2867784A AU 2867784 A AU2867784 A AU 2867784A
- Authority
- AU
- Australia
- Prior art keywords
- aircraft undercarriage
- undercarriage assemblies
- assemblies
- aircraft
- undercarriage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPF9305 | 1983-05-12 | ||
| AUPF9356 | 1983-05-16 | ||
| PCT/JP1984/000085 WO1985003934A1 (en) | 1984-03-06 | 1984-03-06 | Chemically modified protein and process for its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2867784A true AU2867784A (en) | 1984-12-04 |
Family
ID=13818260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28677/84A Abandoned AU2867784A (en) | 1983-05-12 | 1984-05-14 | Aircraft undercarriage assemblies |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | USH1662H (en) |
| JP (2) | JPH0676439B2 (en) |
| KR (1) | KR920007681B1 (en) |
| AU (1) | AU2867784A (en) |
| WO (2) | WO1985003934A1 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3676670D1 (en) * | 1985-06-26 | 1991-02-07 | Cetus Corp | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS BY POLYMER CONJUGATION. |
| US5214131A (en) * | 1988-05-06 | 1993-05-25 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, modified peptides and production thereof |
| GB8824591D0 (en) * | 1988-10-20 | 1988-11-23 | Royal Free Hosp School Med | Fractionation process |
| US5349052A (en) * | 1988-10-20 | 1994-09-20 | Royal Free Hospital School Of Medicine | Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor |
| US5342940A (en) * | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| FR2675807B1 (en) * | 1991-04-23 | 1994-07-01 | Medgenix Group Sa | CONJUGATE OF CALCITONIN AND POLYETHYLENE GLYCOL. |
| US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| DE69800640T2 (en) * | 1997-01-29 | 2001-07-05 | Polymasc Pharmaceuticals Plc, London | PEGYLATION PROCEDURE |
| WO2002014504A1 (en) | 2000-08-11 | 2002-02-21 | Kirin Beer Kabushiki Kaisha | Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| ATE441666T1 (en) | 2001-12-28 | 2009-09-15 | Kyowa Hakko Kirin Co Ltd | ANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR 23 |
| BRPI0306993B8 (en) * | 2002-01-18 | 2021-05-25 | Biogen Idec Inc | activated polyalkylene glycol polymer; composition; and use of a compound in the production of a drug for the treatment of multiple sclerosis or susceptible viral infection. |
| JP2006519170A (en) * | 2002-12-26 | 2006-08-24 | マウンテン ビュー ファーマシューティカルズ,インコーポレイテッド | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones, and their antagonists with conserved receptor binding activity |
| CN102319437B (en) | 2002-12-26 | 2017-10-13 | 山景医药公司 | Polymer conjugates of interferon-beta with enhanced biological utility |
| PT1666496E (en) | 2003-08-25 | 2014-06-24 | Toray Industries | Interferon-beta composite |
| EP1676862B1 (en) | 2003-09-24 | 2010-12-22 | Kyowa Hakko Kirin Co., Ltd. | Recombinant antibody against human insulin-like growth factor |
| US20080199423A1 (en) * | 2004-06-18 | 2008-08-21 | Genentech, Inc. | Methods of Using Apo2l Receptor Agonists and Ink Cell Activators |
| AU2005266892B2 (en) * | 2004-07-29 | 2011-03-03 | Bristol-Myers Squibb Company | Use of IL-28 and IL-29 to treat cancer and autoimmune disorders |
| WO2006080171A1 (en) | 2005-01-31 | 2006-08-03 | Effector Cell Institute, Inc. | Immunopotentiating agent |
| EP1959009A4 (en) | 2005-12-06 | 2010-04-28 | Kyowa Hakko Kirin Co Ltd | GENETICALLY RECOMBINANT ANTI-PERP ANTIBODY |
| EP1997504A1 (en) * | 2006-03-01 | 2008-12-03 | Keio University | Novel antithrombotic agent |
| US7883705B2 (en) | 2007-02-14 | 2011-02-08 | Kyowa Hakko Kirin Co., Ltd. | Anti FGF23 antibody and a pharmaceutical composition comprising the same |
| WO2008114733A1 (en) | 2007-03-16 | 2008-09-25 | Kyowa Hakko Kirin Co., Ltd. | Anti-claudin-4 antibody |
| WO2009072628A1 (en) | 2007-12-05 | 2009-06-11 | Kyowa Hakko Kirin Co., Ltd. | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| KR20110039220A (en) | 2008-06-30 | 2011-04-15 | 교와 핫꼬 기린 가부시키가이샤 | Anti-CD27 antibody |
| KR20110031469A (en) | 2008-07-17 | 2011-03-28 | 교와 핫꼬 기린 가부시키가이샤 | Antibody Asc Amino Acid Transporter 2 (ASCT2) Antibody |
| JP5511686B2 (en) | 2008-12-26 | 2014-06-04 | 協和発酵キリン株式会社 | Anti-CD4 antibody |
| PL2423228T3 (en) | 2009-04-20 | 2016-06-30 | Kyowa Hakko Kirin Co Ltd | Antibody containing igg2 having amino acid mutation introduced therein |
| EP2543727B1 (en) | 2010-03-02 | 2016-08-31 | Kyowa Hakko Kirin Co., Ltd. | Modified antibody composition |
| PT2581113T (en) | 2010-06-11 | 2018-07-04 | Univ Kyushu Nat Univ Corp | Anti-tim-3 antibody |
| AU2012274461A1 (en) | 2011-06-20 | 2014-01-16 | Kyowa Hakko Kirin Co., Ltd. | Anti-erbB3 antibody |
| HK1209769A1 (en) | 2012-07-02 | 2016-04-08 | Kyowa Hakko Kirin Co., Ltd. | Therapeutic agent for anemia including renal anemia and cancer-induced anemia which contains anti-bmp9 antibody as active ingredient |
| TWI614266B (en) | 2012-12-07 | 2018-02-11 | 協和醱酵麒麟有限公司 | anti-FOLR1 antibody |
| US11912775B2 (en) | 2017-07-18 | 2024-02-27 | Kyowa Kirin Co., Ltd. | Anti-human CCR1 monoclonal antibody |
| EP3708589A4 (en) | 2017-11-08 | 2021-08-11 | Kyowa Kirin Co., Ltd. | BISPECIFIC ANTIBODIES THAT BIND TO CD40 AND EpCAM |
| JP7323456B2 (en) | 2017-12-12 | 2023-08-08 | 協和キリン株式会社 | ANTI-BMP10 ANTIBODY AND THERAPEUTIC AGENT FOR HYPERTENSION AND HYPERTENSIVE DISEASE CONTAINING THE ANTIBODY AS AN ACTIVE INGREDIENT |
| MX2021007797A (en) | 2018-12-28 | 2021-10-26 | Kyowa Kirin Co Ltd | BIASPECIFIC ANTIBODY THAT BINDS TO THE TRANSFERRIN RECEPTOR (TFR). |
| US12466891B2 (en) | 2019-05-15 | 2025-11-11 | Kyowa Kirin Co., Ltd. | Bispecific antibody binding to CD40 and GPC3 |
| CN113891728A (en) | 2019-05-15 | 2022-01-04 | 协和麒麟株式会社 | Bispecific antibodies that bind to CD40 and FAP |
| CA3229748A1 (en) | 2021-08-26 | 2023-03-02 | Akifumi Kato | Bispecific antibody that binds to cd116 and cd131 |
| WO2023153471A1 (en) | 2022-02-09 | 2023-08-17 | 国立研究開発法人医薬基盤・健康・栄養研究所 | Antibody or fragment thereof that binds to fcrl1 |
| TW202413406A (en) | 2022-08-10 | 2024-04-01 | 日商協和麒麟股份有限公司 | Anti-FGF23 antibody, and fragment of said antibody |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2433883C2 (en) * | 1973-07-20 | 1986-03-27 | Research Corp., New York, N.Y. | Use of physiologically active polypeptides |
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
| DE2930542A1 (en) * | 1979-07-27 | 1981-02-12 | Hoechst Ag | NEW INSULINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
| JPS57118789A (en) * | 1981-01-13 | 1982-07-23 | Eisai Co Ltd | Modified streptokinase and its preparation |
| JPS57192435A (en) * | 1981-05-20 | 1982-11-26 | Toyobo Co Ltd | Modified polypeptide |
| JPS58154596A (en) * | 1982-03-09 | 1983-09-14 | Toray Ind Inc | Modification of interferon |
-
1984
- 1984-03-06 WO PCT/JP1984/000085 patent/WO1985003934A1/en not_active Ceased
- 1984-05-14 AU AU28677/84A patent/AU2867784A/en not_active Abandoned
- 1984-12-05 WO PCT/JP1984/000575 patent/WO1985003868A1/en not_active Ceased
-
1985
- 1985-02-13 JP JP60027283A patent/JPH0676439B2/en not_active Expired - Lifetime
- 1985-02-26 JP JP60037936A patent/JPH0696599B2/en not_active Expired - Lifetime
- 1985-03-05 KR KR1019850001381A patent/KR920007681B1/en not_active Expired
-
1990
- 1990-04-05 US US07/519,280 patent/USH1662H/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR850006875A (en) | 1985-10-21 |
| JPH0696599B2 (en) | 1994-11-30 |
| WO1985003934A1 (en) | 1985-09-12 |
| JPH0676439B2 (en) | 1994-09-28 |
| USH1662H (en) | 1997-07-01 |
| WO1985003868A1 (en) | 1985-09-12 |
| KR920007681B1 (en) | 1992-09-14 |
| JPS60226821A (en) | 1985-11-12 |
| JPS61178926A (en) | 1986-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2867784A (en) | Aircraft undercarriage assemblies | |
| AU563208B2 (en) | Aircraft seat | |
| GB2145049B (en) | Tandem or multi-winged aircraft | |
| DE3469289D1 (en) | Landing aid for helicopter | |
| AU91013S (en) | An aeroplane | |
| EP0174147A3 (en) | Airplane tyre | |
| AU547328B2 (en) | Aircraft ground proximity warning | |
| AU3301984A (en) | Business form assemblies | |
| AU3396384A (en) | Boride-alumina composite | |
| AU579046B2 (en) | Panel assemblies and methods for making the same | |
| AU2700484A (en) | Composite structure | |
| AU571006B2 (en) | Business form assemblies | |
| GB8421988D0 (en) | Aircraft | |
| GB2134059B (en) | Composite helicopter fuselage | |
| DE3460387D1 (en) | Cabin | |
| AU3749485A (en) | Menetelma ja laitteisto veden jaatymislammon hyvaksikayttamiseksilampopumpun lammonlahteena | |
| GB2134462B (en) | An aircraft undercarriage | |
| GB2168812B (en) | Aircraft landing aid | |
| GB2075448B (en) | Aircraft undercarriage unit | |
| GB2146603B (en) | Auxiliary wings for rotary-winged aircraft | |
| EP0116657A3 (en) | Aircraft retractable undercarriage | |
| GB2143483B (en) | Compound helicopter and powerplant therefor | |
| AU3271984A (en) | Aircraft cabin management terminal | |
| AU578763B2 (en) | Log cabin | |
| PL236360A2 (en) | Aircraft undercarriage |